Detection rates for aneuploidy by first-trimester and sequential screening

Obstetrics and Gynecology

Volumn 126, Issue 4, 2015, Pages 753-759

  Baer, Rebecca J ^a   Flessel, Monica C ^a   Jelliffe Pawlowski, Laura L ^a   Goldman, Sara ^a   Hudgins, Louanne ^a   Hull, Andrew D ^a   Norton, Mary E ^a   Currier, Robert J ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANEUPLOIDY; CHROMOSOME ABERRATION; COHORT ANALYSIS; CONFERENCE PAPER; DOWN SYNDROME; FEMALE; FETUS DEATH; FIRST TRIMESTER PREGNANCY; HUMAN; KLINEFELTER SYNDROME; NEURAL TUBE DEFECT; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; ROBERTSONIAN CHROMOSOME TRANSLOCATION; SECOND TRIMESTER PREGNANCY; SMITH LEMLI OPITZ SYNDROME; TRIPLOIDY; TRISOMY 13; TRISOMY 18; TRISOMY 21; TURNER SYNDROME; UNITED STATES; BLOOD; CHROMOSOME 18; MATERNAL SERUM SCREENING TEST; PREGNANCY; STATISTICS AND NUMERICAL DATA; TRISOMY;

ADULT; ANEUPLOIDY; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FEMALE; HUMANS; MATERNAL SERUM SCREENING TESTS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RETROSPECTIVE STUDIES; TRISOMY;

EID: 84942813059     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001040     Document Type: Conference Paper

References (19)

1. Screening for fetal chromosomal abnormalities. ACOG Practice Bulletin No. 77. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;109:217-27.
2. Currier R, Wu N, van Meter K, Goldman S, Lorey F, Flessel M. Integrated and first trimester prenatal screening in California: program implementation and patient choice for follow-up services. Prenat Diagn 2012;32:1077-83.
3. Kazerouni NN, Currier B, Malm L, Riggle S, Hodgkinson C, Smith S, et al. Triple-marker prenatal screening program for chromosomal defects. Obstet Gynecol 2009;114:50-8.
4. Kazerouni NN, Currier RJ, Flessel M, Goldman S, Hennigan C, Hodgkinson C, et al. Detection rate of quadruple-marker screening determined by clinical follow-up and registry data in the statewide California program, July 2007 to February 2009. Prenat Diagn 2011;31:901-6.
5. Wu N, Platt LD, Greene N, Currier RJ. Practitioner-specific medians for nuchal translucency to improve first-trimester screening performance. Obstet Gynecol 2012;119:785-94.
6. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 2003;10:56-104.
7. Spencer K, Nicolaides KH. A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beta-hCG and PAPP-A. Prenat Diagn 2002;22:877-9.
8. Palomaki GE, Haddow JE, Knight GJ, Wald NJ, Kennard A, Canick JA, et al. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human cho-rionic gonadotropin. Prenat Diagn 1995;15:713-23.
9. Palomaki GE, Bradley LA, Knight GJ, Craig WY, Haddow JE. Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndrome. J Med Screen 2002; 9:43-4.
10. Morris JK, Mutton DE, Alberman E. Revised estimates of the maternal age specific live birth prevalence of Down's syndrome. J Med Screen 2002;9:2-6.
11. Morris JK, Wald NJ, Watt HC. Fetal loss in Down syndrome pregnancies. Prenat Diagn 1999;19:142-5.
12. Wang Y, Sharpe-Stimac M, Cross PK, Druschel CM, Hwang SA. Improving case ascertainment of a population-based birth defects registry in New York State using hospital discharge data. Birth Defects Res A Clin Mol Teratol 2005;73:663-8.
13. Savva GM, Morris JK. Ascertainment and accuracy of Down syndrome cases reported in congenital anomaly registers in England and Wales. Arch Dis Child Fetal Neonatal Ed 2009;94:F23-7.
14. Metcalfe A, Sibbald B, Lowry RB, Tough S, Bernier FP. Validation of congenital anomaly coding in Canada's administrative databases compared with a congenital anomaly registry. Birth Defects Res A Clin Mol Teratol 2014;100:59-66.
15. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353: 2001-11.
16. Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003;349:1405-13.
17. Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A. SURUSS in perspective. BJOG 2004;111:521-31.
18. Baer RJ, Currier RJ, Norton ME, Flessel MC, Goldman S, Towner D, et al. Obstetric, perinatal, and fetal outcomes in pregnancies with false-positive integrated screening results. Obstet Gynecol 2014;123:603-9.
19. Natoli JL, Ackerman DL, McDermott S, Edwards JG. Prenatal diagnosis of Down syndrome: a systematic review of termination rates (1995-2011). Prenat Diagn 2012;32:142-53.